|
|
|
|
|
by meepmorp
1884 days ago
|
|
Yeah, that's what I've read. Basically, even if you could make the necessary mRNA particles properly, the it's useless without the delivery mechanism. Only a few companies even produce the necessary lipid products needed to deliver the vaccine, and they (and their suppliers) are already doing everything they can. The IP concerns had basically zero effect on the availability of vaccines. |
|